ICU Medical sees FY26 adjusted EPS $7.75-$8.45, consensus $8.01

Sees FY26 adjusted EBITDA $400M-$430M. The company said, “For fiscal year 2026 the Company estimates GAAP net income to be in the range of $26 million to $44 million and GAAP net earnings per share estimated to be in the range of $1.03 to $1.74. For the fiscal year 2026, the Company expects adjusted EBITDA to be in the range of $400 million to $430 million, and adjusted EPS to be in the range of $7.75 to $8.45.”